Chardan Healthcare Acquisition 2 Corp (CHAQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CHAQ | LPTX | EPRX | ||
| Company | Chardan Healthcare Acquisition 2 Corp | Leap Therapeutics Inc | Eupraxia Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | ||
| Open | 9.35 | 3.56 | 3.15 | ||
| High | 9.35 | 3.92 | 3.19 | ||
| Low | 8.06 | 3.56 | 3.08 | ||
| Last | 8.41 | 3.71 | 3.11 | ||
| Change | -0.95 | +0.16 | -0.18 | ||
| % Change | -10.15% | +4.51% | -5.37% | ||
| Volume | 242,600 | 342,200 | 7,300 | ||
| 20-Day Average Volume | 87,520 | 470,965 | 19,910 | ||
| Previous Close | 9.36 | 3.55 | 3.29 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 9.87 | 3.20 | 2.61 | ||
| 20-Day Raw Stochastic | 14.23% | 58.30% | 57.14% | ||
| 20-Day Relative Strength | 17.92% | 60.21% | 59.99% | ||
| Weighted Alpha | -24.94 | +54.93 | -3.94 | ||
| Today's Opinion | 100% Sell | 88% Buy | 16% Sell | ||
| Previous Opinion | 100% Sell | 88% Buy | 24% Sell | ||
| Last Month's Opinion | 40% Sell | 24% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.07% since 08/26/21 | -11.03% since 10/30/24 | +27.93% since 10/29/24 | ||
| Low | 8.06 on 09/02/21 | 3.40 on 11/04/24 | 2.47 on 10/30/24 | ||
| High | 10.52 on 08/30/21 | 4.24 on 10/31/24 | 3.79 on 11/01/24 | ||
| 1-Month | |||||
| %Chg | -16.65% since 08/02/21 | +44.92% since 10/04/24 | +17.31% since 10/04/24 | ||
| Low | 8.06 on 09/02/21 | 2.20 on 10/15/24 | 2.20 on 10/14/24 | ||
| High | 10.52 on 08/30/21 | 4.79 on 10/30/24 | 3.79 on 11/01/24 | ||
| 3-Month | |||||
| %Chg | -16.36% since 06/02/21 | +72.56% since 08/06/24 | +24.34% since 08/06/24 | ||
| Low | 8.06 on 09/02/21 | 2.01 on 08/08/24 | 2.20 on 10/14/24 | ||
| High | 10.52 on 08/30/21 | 4.79 on 10/30/24 | 3.79 on 11/01/24 | ||
| 6-Month | |||||
| %Chg | -17.39% since 03/02/21 | +15.22% since 05/06/24 | +8.66% since 05/06/24 | ||
| Low | 8.06 on 09/02/21 | 1.68 on 07/02/24 | 2.20 on 10/14/24 | ||
| High | 10.52 on 08/30/21 | 4.79 on 10/30/24 | 3.79 on 11/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 90,643 | 90,880 | 89,621 | ||
| Shares Outstanding, K | 10,778 | 25,600 | 27,282 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -780,000 | -81,410,000 | -28,220,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -490,000 | -20,130,000 | -6,010,000 | ||
| 60-Month Beta | 0.05 | 0.22 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 08/17/21 | -0.52 on 08/12/24 | -0.17 on 08/07/24 | ||
| Latest Earnings Date | N/A | 11/11/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||